Bicycle Therapeutics plc American Depositary Shares
$3.68
$0.03 (+0.96%)
$3.67Day Range$3.79
Key Statistics
Market Cap
$254.77M
Shares Outstanding
70.0M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
May 23, 2019
Round Lot
100
Locale
US
Trading Data
Day Open
$3.73
Day High
$3.79
Day Low
$3.67
Volume
117.1K
VWAP
$3.74
Prev Close
$3.64
Transactions
--
Acc. Volume
--
About Bicycle Therapeutics plc American Depositary Shares
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
PHARMACEUTICAL PREPARATIONSSIC 2834288 employeesBLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, X0, CB21 6GS011441223261503IPO May 23, 2019US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001761612
- Composite FIGI
- BBG00P0YWPK6
- Share Class FIGI
- BBG00P0YWQ97
- Ticker Root
- BCYC
- SIC Code
- 2834
About Bicycle Therapeutics plc American Depositary Shares (BCYC) Stock
Bicycle Therapeutics plc American Depositary Shares (BCYC) closed the 2026-09-17 session at $3.67, up 0.96% versus the previous close (+0.03). The stock opened at $3.73 and traded between $3.67 and $3.79 during that session. Session trading volume was 117K shares. The volume-weighted average price (VWAP) is $3.74.
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Bicycle Therapeutics plc American Depositary Shares has a market capitalization of $254.8 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. BCYC is listed on the XNAS exchange. The company employs approximately 288 people. Bicycle Therapeutics plc American Depositary Shares is headquartered in CAMBRIDGE, X0. The recorded listing date is 2019-05-23.
On this page you can find market BCYC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.